MARKET

MSLE

MSLE

Satellos Bioscience Inc
NASDAQ
7.49
+0.30
+4.17%
After Hours: 7.49 0 0.00% 19:30 11/09 EST
OPEN
7.21
PREV CLOSE
7.19
HIGH
7.53
LOW
7.01
VOLUME
31.18K
TURNOVER
--
52 WEEK HIGH
13.39
52 WEEK LOW
5.44
MARKET CAP
158.91M
P/E (TTM)
-3.7790
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Satellos Bioscience (MSLE) and Protara Therapeutics (TARA)
TipRanks · 15h ago
Weekly Report: what happened at MSLE last week (1102-1106)?
Weekly Report · 18h ago
Satellos Changes BASECAMP Endpoint After FDA Feedback; Data Expected In Q1 2027
NASDAQ · 3d ago
Satellos Changes Primary Endpoint in Pediatric Duchenne Trial After FDA Feedback
TipRanks · 3d ago
Satellos Bioscience Switches BASECAMP Phase 2 Primary Endpoint To MRI Fat Fraction Following FDA Feedback
Benzinga · 3d ago
Satellos to Update Investors on BASECAMP DMD Study Strategy
TipRanks · 4d ago
Weekly Report: what happened at MSLE last week (1026-1030)?
Weekly Report · 11/02 09:13
Weekly Report: what happened at MSLE last week (1019-1023)?
Weekly Report · 10/26 09:13
More
About MSLE
Satellos Bioscience Inc. is a Canada-based clinical-stage drug development company. The Company is focused on restoring natural muscle repair and regeneration in degenerative muscle diseases. Through its research, the Company has developed SAT-3247, a first-of-its-kind, orally administered small molecule drug designed to address deficits in muscle repair and regeneration. SAT-3247 targets AAK1, a key protein that has identified as capable of replacing the signal normally provided by dystrophin in muscle stem cells to effect repair and regeneration. It is also leveraging its proprietary discovery platform MyoReGenX to identify additional muscle diseases or injury conditions where restoring muscle repair and regeneration may have therapeutic benefit and represent future clinical development opportunities. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process.

Webull offers Satellos Bioscience Inc stock information, including NASDAQ: MSLE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MSLE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MSLE stock methods without spending real money on the virtual paper trading platform.